BioXcel Therapeutics, Inc. (BTAI) Shareholders’ equity 2022–2025
BioXcel Therapeutics, Inc. (BTAI) shareholders’ equity at each fiscal year-end, per SEC filings.
-$95.5MFY2025 · since FY2022: $76.8M → -$95.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$95.5M | -2.5% |
| FY2024 | -$93.1M | -64.8% |
| FY2023 | -$56.5M | -173.6% |
| FY2022 | $76.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice